Franklin Resources
CTIC

Franklin Resources’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Franklin Resources’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,472,300
Closed -$17.3M – 1572
2018
Q2 		$17.3M Hold
3,472,300
– – 0.01% 809
2018
Q1 		$13.5M Buy
+3,472,300
New +$12.2M 0.01% 869

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Franklin Resources's CTIC Position: Q3 2018 in Review

Franklin Resources sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2018, closing a stake of 3,472,300 shares — an estimated $17.3M sold.

Franklin Resources first reported a position in CTIC in Q1 2018 and held it in 2 quarters. The position peaked at $17.3M in Q2 2018. 79 funds tracked by Wall St. Rank hold CTIC as of Q3 2018.

  • Franklin Resources reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2018 after selling out during the quarter.
  • Franklin Resources sold 3,472,300 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2018, an estimated $17.3M.
  • Franklin Resources first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q1 2018 and held it in 2 quarters.
  • Franklin Resources's CTI BioPharma Corp. (DE) Common Stock position peaked at $17.3M in Q2 2018.
  • 79 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2018.

Based on Franklin Resources's 13F filing for Q3 2018, filed 13 Nov 2018.